31 March 2020 - Morning meeting - Login for venue
With the increasing importance of the life sciences sector and the big transitional changes affecting the UK economy, it is timely to consider whether the framework in which the industry operates provides the best possible conditions for innovation. In particular, the question arises whether the current patent system is still fit for purpose, particularly for incentivising the development of advanced therapy medicinal products, and whether we need to look to alternative models. This roundtable will bring together policymakers and industry experts to discuss such issues and what could be done to better incentivise innovation.
Sponsors: Pinsent Masons LLP